APLM
Apollomics, Inc.NASDAQHealthcare$14.12-4.89%ClosedMarket Cap: $15.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-3.51
P/S
2.23
EV/EBITDA
-0.50
DCF Value
$6.98
FCF Yield
-82.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
-22.7%
Operating Margin
-395.9%
Net Margin
-450.0%
ROE
-13385.4%
ROA
-280.5%
ROIC
-3227.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $8.5M | 0.0% | $-10.6M | $-12.5M | $-11.37 | — |
| Q4 2024 | $-1.6M | 100.0% | $-16.8M | $-18.7M | $-16.92 | — |
| FY 2024 | $198.0K | 100.0% | $-42.1M | $-53.9M | $-52.80 | — |
| Q2 2024 | $1.8M | 100.0% | $-25.3M | $-35.2M | $-38.00 | — |
| Q4 2023 | $333.0K | 100.0% | $-28.3M | $-21.9M | $-0.24 | — |
| FY 2023 | $821.0K | 100.0% | $-54.0M | $-172.6M | $-231.99 | — |
| Q2 2023 | $488.0K | 100.0% | $-25.7M | $-150.7M | $-2.56 | — |
| Q4 2022 | $-272.0K | 100.0% | $-22.6M | $-237.4M | $-0.00 | — |
| FY 2022 | $323.0K | 100.0% | $-45.1M | $-240.8M | $-61.60 | — |
| Q2 2022 | $595.0K | 100.0% | $-22.5M | $-3.4M | $-0.05 | — |
| Q4 2021 | $-53.0K | 100.0% | $-25.4M | $-28.3M | $0.00 | — |
| FY 2021 | $2.0K | 100.0% | $-50.9M | $-94.8M | $-23.45 | — |